Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adoption of digital tools in the context of the COVID-19 pandemic in the Region of the Americas - the Go.Data experience.
Valencia C, Jaramillo-Gutierrez G, Rearte A, Rosin P, Gassino F, Morreale SE, Gobern L, Paredes A, Rondy M, Balsells E, Galindo P, Parra L, Mazariegos O, Young A, Bhavnani D, Miri A, Iken D, James E, Rodriguez A. Valencia C, et al. Among authors: rearte a. Lancet Reg Health Am. 2022 Dec;16:100377. doi: 10.1016/j.lana.2022.100377. Epub 2022 Oct 6. Lancet Reg Health Am. 2022. PMID: 36246768 Free PMC article. Review.
Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children.
Pecenka C, Sparrow E, Feikin DR, Srikantiah P, Darko DM, Karikari-Boateng E, Baral R, Vizzotti C, Rearte A, Jalang'o R, Fleming JA, Martinón-Torres F, Karron RA. Pecenka C, et al. Among authors: rearte a. Lancet. 2024 Sep 21;404(10458):1157-1170. doi: 10.1016/S0140-6736(24)01699-4. Epub 2024 Sep 9. Lancet. 2024. PMID: 39265588 Review.
Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
Rearte A, Castelli JM, Rearte R, Fuentes N, Pennini V, Pesce M, Barbeira PB, Iummato LE, Laurora M, Bartolomeu ML, Galligani G, Del Valle Juarez M, Giovacchini CM, Santoro A, Esperatti M, Tarragona S, Vizzotti C. Rearte A, et al. Lancet. 2022 Mar 26;399(10331):1254-1264. doi: 10.1016/S0140-6736(22)00011-3. Epub 2022 Mar 15. Lancet. 2022. PMID: 35303473 Free PMC article.
Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
Vizzotti C, González J, Rearte A, Urueña A, Pérez Carrega M, Calli R, Gentile A, Uboldi A, Ramonet M, Cañero-Velasco M, Diosque M. Vizzotti C, et al. Among authors: rearte a. J Pediatric Infect Dis Soc. 2015 Dec;4(4):e62-7. doi: 10.1093/jpids/piu068. Epub 2014 Jul 11. J Pediatric Infect Dis Soc. 2015. PMID: 26582885
Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina: High Prevalence of Protective Antibodies up to 9 Years After Vaccination.
Urueña A, González JE, Rearte A, Pérez Carrega ME, Calli R, Pagani MF, Uboldi A, Vicentín R, Caglio P, Cañero-Velasco MC, Gentile A, Ramonet M, Vizzotti C. Urueña A, et al. Among authors: rearte a. Pediatr Infect Dis J. 2016 Dec;35(12):1339-1342. doi: 10.1097/INF.0000000000001322. Pediatr Infect Dis J. 2016. PMID: 27636725
Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: vaccination impact.
Ruvinsky RO, Rearte A, Kupervaser J, Gentile F, Haidar A, Cafure ME, Tito ME, Avaro F, Cortiana C, Cozzani H, Véliz O, Fossati S, Regueira M, Vizzotti C. Ruvinsky RO, et al. Among authors: rearte a. Rev Panam Salud Publica. 2018 Nov 9;42:e167. doi: 10.26633/RPSP.2018.167. eCollection 2018. Rev Panam Salud Publica. 2018. PMID: 31093195 Free PMC article.
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Pascuale CA, Varese A, Ojeda DS, Pasinovich ME, Lopez L, Rossi AH, Rodriguez PE, Miglietta EA; Laboratorio SeVa Group; Mazzitelli I, Di Diego Garcia F, Sanchez L, Rouco SO, Gonzalez Lopez Ledesma MM, Zurano JP, Mazzitelli B, Scruzzi G, Barbero P, Cardozo D, Gallego S, Borda M, Diaz M; Ministerio de Salud de la Provincia de Córdoba Group; UNC-Fac. Cs. Médicas-InViV Group; Ridao F, Rosales AB; Ministerio de Salud de la Provincia de La Rioja Group; Bhon J, Talia JM, Diangelo ME, Lacaze MA; Ministerio de Salud de la Provincia de San Luis Group; Aime B, Gutierrez SI, Ercole R, Toro R, Tau L, Delaplace L, Compagnucci MF; Universidad Nacional de La Plata Group; Sartori C, Desimone I, Echegoyen C, Velazquez P, Testa C; Ministerio de Salud de la Provincia de Buenos Aires Group; Hozbor D, Docena G, Laino CH, Kreplak N, Pifano M, Barbas G, Rearte A, Vizzotti C, Castelli JM, Geffner J, Gamarnik AV. Pascuale CA, et al. Among authors: rearte a. Cell Rep Med. 2022 Aug 16;3(8):100706. doi: 10.1016/j.xcrm.2022.100706. Epub 2022 Aug 3. Cell Rep Med. 2022. PMID: 35926505 Free PMC article.
21 results